Dirk Kuyper, Alphatec Spine’s president and CEO, attributed the company’s success to the launch of several new products during the third quarter, including PureGen technologies.
The company reported $30 million in U.S. revenues, an increase of 15.2 percent from the third quarter of 2009. The gross profit for the third quarter was reported as $28.9 million, a 44.1 percent increase over the third quarter of 2009.
Read the release on Alphatec Spine’s 3Q FY 2010 financial report.
Read other coverage on Alphatec Spine:
– Alphatec Spine Signs Agreement With Merlot OrthopediX for Spine Surgery Technology
– Alphatec Spine Receives CE mark of Approval for Spinal Systems
– Alphatec Holdings Names Former Johnson & Johnson CFO as New CFO
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.